Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
BARR URGES FDA TO WITHDRAW ANDAs BY PAR, QUAD, ATI, PBI; FDA HAS LEGAL AND MORAL OBLIGATION TO VOID APPROVALS "TAINTED BY FRAUD," BARR SAYS
Jun 19 1989
•
By
The Pink Sheet
More from Archive
More from Pink Sheet